Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading on Nasdaq under the ticker PWUP, is a blank-check company formed to pursue an acquisition target in the biopharma and life sciences sector. The company filed a 10-Q with the SEC on August 8, 2023, reflecting its continued status as a SPAC in the search phase following its IPO in 2021. The filing covers routine quarterly disclosures required of registered shell companies still seeking a definitive business combination. PWUP joins a cohort of healthcare-focused SPACs navigating an extended deal-search environment marked by tightened market conditions across the biopharma space. Visit SpacDesk and sign up for full access to PWUP's filing history, timeline data, and deal-status tracking.